Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013.
暂无分享,去创建一个
Arun Ravindran | Michael Berk | Roumen Milev | Eduard Vieta | Kyooseob Ha | Sagar V Parikh | Joseph R Calabrese | Martin Alda | Flávio Kapczinski | Claire O'Donovan | Sidney H Kennedy | Roger S McIntyre | Glenda MacQueen | J. Calabrese | M. Alda | A. Young | W. Nolen | S. Kennedy | R. McIntyre | G. MacQueen | B. Frey | M. Berk | Verinder Sharma | E. Vieta | Kyooseob Ha | R. Milev | S. Parikh | A. Ravindran | F. Kapczinski | B. Birmaher | B. Goldstein | B. Lafer | S. Beaulieu | D. Bond | L. Yatham | L. Young | C. O’Donovan | A. Schaffer | Ayal Schaffer | Serge Beaulieu | Lakshmi N Yatham | Verinder Sharma | L Trevor Young | Allan H Young
[1] A. Beekman,et al. Risk factors for cognitive impairment in elderly bipolar patients. , 2010, Journal of affective disorders.
[2] B. Källén,et al. Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data , 2010, Psychological Medicine.
[3] C. Depp,et al. Medication adherence skills training for middle-aged and elderly adults with bipolar disorder: development and pilot study. , 2007, Bipolar disorders.
[4] C. Correll. Weight gain and metabolic effects of mood stabilizers and antipsychotics in pediatric bipolar disorder: a systematic review and pooled analysis of short-term trials. , 2007, Journal of the American Academy of Child and Adolescent Psychiatry.
[5] G. Sachs,et al. Evaluation of akathisia in patients with schizophrenia, schizoaffective disorder, or bipolar I disorder: a post hoc analysis of pooled data from short- and long-term aripiprazole trials , 2010, Journal of psychopharmacology.
[6] H. Grunze,et al. A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder. , 2005, The Journal of clinical psychiatry.
[7] Andrea Cipriani,et al. Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis , 2011, The Lancet.
[8] S. Strejilevich,et al. Cognitive and motor features in elderly people with bipolar disorder. , 2008, Journal of affective disorders.
[9] R. Hirschfeld,et al. Quetiapine for the treatment of bipolar II depression: Analysis of data from two randomized, double-blind, placebo-controlled studies , 2008, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.
[10] G. Sachs,et al. Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study. , 2004, Bipolar disorders.
[11] R. Porter,et al. Comparison of Insulin Resistance, Metabolic Syndrome and Adiponectin in Overweight Bipolar Patients Taking Sodium Valproate and Controls , 2009, The Australian and New Zealand journal of psychiatry.
[12] P. Andersen,et al. Lithium treatment and risk of dementia. , 2008, Archives of general psychiatry.
[13] S. Kennedy,et al. Medical comorbidity in bipolar disorder: implications for functional outcomes and health service utilization. , 2006, Psychiatric services.
[14] S. Potkin,et al. Rapid and Sustained Antidepressant Response with Sleep Deprivation and Chronotherapy in Bipolar Disorder , 2009, Biological Psychiatry.
[15] W. Nolen,et al. Continuation of quetiapine versus switching to placebo or lithium for maintenance treatment of bipolar I disorder (Trial 144: a randomized controlled study). , 2011, The Journal of clinical psychiatry.
[16] M. Sidor,et al. Antidepressants for the acute treatment of bipolar depression: a systematic review and meta-analysis. , 2011, The Journal of clinical psychiatry.
[17] M. Tohen,et al. Olanzapine versus lithium in the acute treatment of bipolar mania: a double-blind, randomized, controlled trial. , 2008, Journal of affective disorders.
[18] M. Thase,et al. Aripiprazole Monotherapy in Nonpsychotic Bipolar I Depression: Results of 2 Randomized, Placebo-Controlled Studies , 2008, Journal of clinical psychopharmacology.
[19] A. Sicras-Mainar,et al. Metabolic syndrome in outpatients receiving antipsychotic therapy in routine clinical practice: A cross-sectional assessment of a primary health care database , 2008, European Psychiatry.
[20] L. Rohde,et al. Methylphenidate combined with aripiprazole in children and adolescents with bipolar disorder and attention-deficit/hyperactivity disorder: a randomized crossover trial. , 2009, Journal of child and adolescent psychopharmacology.
[21] N. Rasgon,et al. Open adjunctive ziprasidone associated with weight loss in obese and overweight bipolar disorder patients. , 2011, Journal of psychiatric research.
[22] M. Tohen,et al. Effectiveness and Safety of the Combination of Fluoxetine and Olanzapine in Outpatients With Bipolar Depression: An Open-Label, Randomized, Flexible-Dose Study in Puerto Rico , 2009, Journal of clinical psychopharmacology.
[23] David J Kupfer,et al. Cardiovascular disease and hypertension among adults with bipolar I disorder in the United States. , 2009, Bipolar disorders.
[24] O. Mors,et al. Family and partner psychopathology and the risk of postpartum mental disorders. , 2007, The Journal of clinical psychiatry.
[25] E. Vieta,et al. Quetiapine in the treatment of acute mania: target dose for efficacious treatment. , 2007, Journal of affective disorders.
[26] S. Strakowski,et al. A double-blind, placebo-controlled pilot study of quetiapine for depressed adolescents with bipolar disorder. , 2009, Bipolar disorders.
[27] A. Rush,et al. Do atypical antipsychotics effectively treat co-occurring bipolar disorder and stimulant dependence? A randomized, double-blind trial. , 2008, The Journal of clinical psychiatry.
[28] G. Parker,et al. SSRIs as mood stabilizers for Bipolar II Disorder? A proof of concept study. , 2006, Journal of affective disorders.
[29] M. Zimmerman,et al. Borderline personality disorder and the misdiagnosis of bipolar disorder. , 2010, Journal of psychiatric research.
[30] T. Suppes,et al. Randomized, placebo-controlled trial of risperidone for acute treatment of bipolar anxiety. , 2009, Journal of affective disorders.
[31] J. Kulkarni,et al. 323 – Tamoxifen — a potential treatment for women in the manic phase of bipolar affective disorder? , 2008, Schizophrenia Research.
[32] M. Loane,et al. Intrauterine exposure to carbamazepine and specific congenital malformations: systematic review and case-control study , 2010, BMJ : British Medical Journal.
[33] C. Gau,et al. Association between mood stabilizers and hypothyroidism in patients with bipolar disorders: a nested, matched case-control study. , 2010, Bipolar disorders.
[34] C. Born,et al. Aripiprazole as adjunct to a mood stabilizer and citalopram in bipolar depression: a randomized placebo‐controlled pilot study , 2010, Human psychopharmacology.
[35] M. Alda,et al. Cross-prevalence of migraine and bipolar disorder. , 2010, Bipolar disorders.
[36] M. Thase,et al. The prospective course of rapid-cycling bipolar disorder: findings from the STEP-BD. , 2008, The American journal of psychiatry.
[37] E. Isometsä,et al. Adequacy of treatment received by diagnosed and undiagnosed patients with bipolar I and II disorders. , 2007, The Journal of clinical psychiatry.
[38] J. Calabrese,et al. Quetiapine for the treatment of bipolar mania in older adults. , 2008, Bipolar disorders.
[39] N. Rasgon,et al. Increased depressive symptoms in menopausal age women with bipolar disorder: age and gender comparison. , 2009, Journal of psychiatric research.
[40] Tammas Kelly,et al. The use of triiodothyronine as an augmentation agent in treatment-resistant bipolar II and bipolar disorder NOS. , 2009, Journal of affective disorders.
[41] J. Calabrese,et al. Methylphenidate in the treatment of children and adolescents with bipolar disorder and attention-deficit/hyperactivity disorder. , 2007, Journal of the American Academy of Child and Adolescent Psychiatry.
[42] S. Kennedy,et al. The rate of metabolic syndrome in euthymic Canadian individuals with bipolar I/II disorder , 2010, Advances in therapy.
[43] J. Biederman,et al. Comparison of open-label, 8-week trials of olanzapine monotherapy and topiramate augmentation of olanzapine for the treatment of pediatric bipolar disorder. , 2009, Journal of child and adolescent psychopharmacology.
[44] Rebecca Tillman,et al. Psychotic phenomena in 257 young children and adolescents with bipolar I disorder: delusions and hallucinations (benign and pathological). , 2008, Bipolar disorders.
[45] J. Rendell,et al. Olanzapine in the long-term treatment of bipolar disorder: A systematic review and meta-analysis , 2010, Journal of psychopharmacology.
[46] L. Judd,et al. Residual symptom recovery from major affective episodes in bipolar disorders and rapid episode relapse/recurrence. , 2008, Archives of general psychiatry.
[47] N. Craddock,et al. Beating Bipolar: exploratory trial of a novel Internet-based psychoeducational treatment for bipolar disorder. , 2011, Bipolar disorders.
[48] J. Biederman,et al. A prospective open-label trial of extended-release carbamazepine monotherapy in children with bipolar disorder. , 2010, Journal of child and adolescent psychopharmacology.
[49] J. Biederman,et al. Omega-3 fatty acid monotherapy for pediatric bipolar disorder: A prospective open-label trial , 2007, European Neuropsychopharmacology.
[50] A. Young,et al. A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I). , 2010, The Journal of clinical psychiatry.
[51] J. Calabrese,et al. Predictors of non-stabilization during the combination therapy of lithium and divalproex in rapid cycling bipolar disorder: a post-hoc analysis of two studies. , 2010, Psychopharmacology bulletin.
[52] S. Strakowski,et al. The efficacy and tolerability of quetiapine versus divalproex for the treatment of impulsivity and reactive aggression in adolescents with co-occurring bipolar disorder and disruptive behavior disorder(s). , 2006, Journal of child and adolescent psychopharmacology.
[53] M. Thase,et al. A history of childhood attention‐deficit hyperactivity disorder (ADHD) impacts clinical outcome in adult bipolar patients regardless of current ADHD , 2009, Acta psychiatrica Scandinavica.
[54] F. Johnson,et al. Factors That Affect Adherence to Bipolar Disorder Treatments: A Stated-Preference Approach , 2007, Medical care.
[55] M. Stek,et al. Cognitive functioning in elderly patients with early onset bipolar disorder , 2007, International journal of geriatric psychiatry.
[56] Megan M. Filkowski,et al. A prospective, open-label study of Aripiprazole mono- and adjunctive treatment in acute bipolar depression. , 2008, Journal of affective disorders.
[57] N. Ryan,et al. Four-year longitudinal course of children and adolescents with bipolar spectrum disorders: the Course and Outcome of Bipolar Youth (COBY) study. , 2009, The American journal of psychiatry.
[58] P. Buckley. Family-Focused Treatment for Adolescents With Bipolar Disorder: Results of a 2-Year Randomized Trial , 2009 .
[59] L. Judd,et al. Anxiety and outcome in bipolar disorder. , 2009, The American journal of psychiatry.
[60] M. Frye,et al. A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders. , 2000, Journal of clinical psychopharmacology.
[61] P. Keck,et al. Randomized, double-blind, placebo-controlled study of divalproex extended release loading monotherapy in ambulatory bipolar spectrum disorder patients with moderate-to-severe hypomania or mild mania. , 2010, The Journal of clinical psychiatry.
[62] Verinder Sharma,et al. DSM-V: modifying the postpartum-onset specifier to include hypomania , 2010, Archives of Women's Mental Health.
[63] J. Calabrese,et al. Quetiapine monotherapy in the treatment of patients with bipolar I or II depression and a rapid-cycling disease course: a randomized, double-blind, placebo-controlled study. , 2007, Bipolar disorders.
[64] D. James,et al. Tobacco smoking behaviors in bipolar disorder: a comparison of the general population, schizophrenia, and major depression. , 2009, Bipolar disorders.
[65] N. Herrmann,et al. Effect of antidepressant use on admissions to hospital among elderly bipolar patients , 2006, International journal of geriatric psychiatry.
[66] H. Corrêa,et al. Suicidal behavior in bipolar disorder: what is the influence of psychiatric comorbidities? , 2009, The Journal of clinical psychiatry.
[67] E. Bora,et al. Meta‐analytic review of neurocognition in bipolar II disorder , 2011, Acta psychiatrica Scandinavica.
[68] E. Vieta,et al. Efficacy of adjunctive aripiprazole to either valproate or lithium in bipolar mania patients partially nonresponsive to valproate/lithium monotherapy: a placebo-controlled study. , 2008, The American journal of psychiatry.
[69] N. Ryan,et al. Concerns regarding the inclusion of temper dysregulation disorder with dysphoria in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. , 2011, The Journal of clinical psychiatry.
[70] M. Jakovljevič,et al. Mental disorders and metabolic syndrome: a fatamorgana or warning reality? , 2007, Psychiatria Danubina.
[71] I. Levav,et al. Enhanced cancer risk among patients with bipolar disorder. , 2008, Journal of affective disorders.
[72] E. Vieta,et al. Ziprasidone in the treatment of acute mania: a 12-week, placebo-controlled, haloperidol-referenced study , 2010, Journal of Psychopharmacology.
[73] Christina L. Wichman. Atypical antipsychotic use in pregnancy: a retrospective review , 2009, Archives of Women's Mental Health.
[74] K. Merikangas,et al. Specificity of bipolar spectrum conditions in the comorbidity of mood and substance use disorders: results from the Zurich cohort study. , 2008, Archives of general psychiatry.
[75] E. Vieta,et al. Aripiprazole monotherapy in the treatment of bipolar disorder: a meta-analysis , 2010, Journal of affective disorders.
[76] M. Versavel,et al. Psychosocial functioning and health-related quality of life in children and adolescents treated with open-label ziprasidone for bipolar mania, schizophrenia, or schizoaffective disorder. , 2009, Journal of child and adolescent psychopharmacology.
[77] M. DelBello,et al. Risperidone for the treatment of acute mania in children and adolescents with bipolar disorder: a randomized, double-blind, placebo-controlled study. , 2009, Bipolar disorders.
[78] G. L’italien,et al. Hyperlipidemia following treatment with antipsychotic medications. , 2006, The American journal of psychiatry.
[79] E. Vieta,et al. A randomized, placebo- and active-controlled study of paliperidone extended release for the treatment of acute manic and mixed episodes of bipolar I disorder. , 2010, Bipolar disorders.
[80] David Taylor,et al. Pharmacological interventions for acute bipolar mania: a systematic review of randomized placebo-controlled trials. , 2007, Bipolar disorders.
[81] K. Min,et al. Risperidone in the treatment of mixed state bipolar patients: Results from a 24‐week, multicenter, open‐label study in Korea , 2010, Psychiatry and clinical neurosciences.
[82] A. Nierenberg,et al. Development of an Integrated Psychosocial Treatment to Address the Medical Burden Associated with Bipolar Disorder , 2011, Journal of psychiatric practice.
[83] J. Calabrese,et al. Adjunctive antidepressant use and symptomatic recovery among bipolar depressed patients with concomitant manic symptoms: findings from the STEP-BD. , 2007, The American journal of psychiatry.
[84] Jan M Friedman,et al. Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects. , 2007, The New England journal of medicine.
[85] P. Keck,et al. A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania. , 2003, The American journal of psychiatry.
[86] J. Biederman,et al. A prospective open-label treatment trial of ziprasidone monotherapy in children and adolescents with bipolar disorder. , 2007, Bipolar disorders.
[87] A. Beekman,et al. Cognitive impairment in early and late bipolar disorder. , 2009, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[88] Acog Practice Bulletin. Clinical Management Guidelines for Obstetrician-Gynecologists Use of Psychiatric Medications During Pregnancy and Lactation , 2009 .
[89] R. Baldessarini,et al. Levetiracetam for manic behavior in hospitalized geriatric patients with dementia of the Alzheimer's type. , 2007, Journal of clinical psychopharmacology.
[90] M. Brecher,et al. P0160 - A double-blind, placebo-controlled study with acute and continuation phase of Quetiapine and Lithium in adults with bipolar depression (Embolden I) , 2008, European Psychiatry.
[91] Allison Hadley,et al. A Naturalistic, Single-blind Comparison of Rapid Dose Administration of Divalproex ER Versus Quetiapine in Patients with Acute Bipolar Mania. , 2011, Innovations in clinical neuroscience.
[92] L. Rollin,et al. Efficacy of aripiprazole adjunctive to lithium or valproate in the long‐term treatment of patients with bipolar I disorder with an inadequate response to lithium or valproate monotherapy: a multicenter, double‐blind, randomized study , 2011, Bipolar disorders.
[93] M. DelBello,et al. Antipsychotic and mood stabilizer efficacy and tolerability in pediatric and adult patients with bipolar I mania: a comparative analysis of acute, randomized, placebo-controlled trials. , 2010, Bipolar disorders.
[94] L. Alphs,et al. A randomized, double-blind, placebo-controlled study of maintenance treatment with adjunctive risperidone long-acting therapy in patients with bipolar I disorder who relapse frequently. , 2009, Bipolar disorders.
[95] A. Szegedi,et al. PW01-28 - Asenapine as Adjunctive Treatment For Bipolar Mania: A Placebo-controlled 12-week Study and 40-week Extension , 2010, European psychiatry.
[96] David J Miklowitz,et al. Effectiveness of adjunctive antidepressant treatment for bipolar depression. , 2007, The New England journal of medicine.
[97] R. Tabarés-Seisdedos,et al. Effects of atypical antipsychotics on neurocognition in euthymic bipolar patients , 2010, Comprehensive psychiatry.
[98] R. McIntyre,et al. Asenapine for long-term treatment of bipolar disorder: a double-blind 40-week extension study. , 2010, Journal of Affective Disorders.
[99] M. Loane,et al. Valproic acid monotherapy in pregnancy and major congenital malformations. , 2010, The New England journal of medicine.
[100] T. Suppes,et al. Effectiveness of the extended release formulation of quetiapine as monotherapy for the treatment of acute bipolar depression. , 2010, Journal of affective disorders.
[101] J. Calabrese,et al. A randomized, double-blind, placebo-controlled 26-week trial of aripiprazole in recently manic patients with bipolar I disorder. , 2006, The Journal of clinical psychiatry.
[102] M. DelBello,et al. Long-term safety of divalproex sodium extended-release in children and adolescents with bipolar I disorder. , 2009, Journal of child and adolescent psychopharmacology.
[103] G. Sachs,et al. Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder: a 3-week placebo-controlled study , 2006, Journal of psychopharmacology.
[104] P. Sparén,et al. Psychotic Illness in First-Time Mothers with No Previous Psychiatric Hospitalizations: A Population-Based Study , 2009, PLoS medicine.
[105] E. Vieta,et al. Treatment Options for Bipolar Depression: A Systematic Review of Randomized, Controlled Trials , 2010, Journal of clinical psychopharmacology.
[106] G. Goodwin,et al. Risperidone alone or in combination for acute mania. , 2006, The Cochrane database of systematic reviews.
[107] P. Gean,et al. The role of valproate in metabolic disturbances in bipolar disorder patients. , 2010, Journal of affective disorders.
[108] S. Kennedy,et al. Attention-deficit/hyperactivity disorder in adults with bipolar disorder or major depressive disorder: results from the international mood disorders collaborative project. , 2010, Primary care companion to the Journal of clinical psychiatry.
[109] B. Kalra,et al. Efficacy of Sodium Valproate and Haloperidol in the Management of Acute Mania: A Randomized Open‐Label Comparative Study , 2010, Journal of clinical pharmacology.
[110] J. Biederman,et al. An Open-Label Trial of Aripiprazole Monotherapy in Children and Adolescents with Bipolar Disorder , 2007, CNS Spectrums.
[111] M. Bartels,et al. Oxcarbazepine treatment during breast-feeding: a case report. , 2007, Journal of clinical psychopharmacology.
[112] J. Calabrese,et al. A randomized, placebo-controlled, multicenter study of divalproex sodium extended release in the treatment of acute mania. , 2006, The Journal of clinical psychiatry.
[113] D. Luckenbaugh,et al. A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression. , 2010, Archives of general psychiatry.
[114] L. Citrome,et al. Risk of Treatment-Emergent Diabetes Mellitus in Patients Receiving Antipsychotics , 2007, The Annals of pharmacotherapy.
[115] R. Ownby,et al. A Double‐Blind Study of Lorazepam versus the Combination of Haloperidol and Lorazepam in Managing Agitation , 1998, Pharmacotherapy.
[116] M. Tohen,et al. Level of response and safety of pharmacological monotherapy in the treatment of acute bipolar I disorder phases: a systematic review and meta-analysis. , 2010, The international journal of neuropsychopharmacology.
[117] R. Jacobs,et al. Child and family-focused cognitive-behavioral therapy for pediatric bipolar disorder: pilot study of group treatment format. , 2009, Journal of the Canadian Academy of Child and Adolescent Psychiatry = Journal de l'Academie canadienne de psychiatrie de l'enfant et de l'adolescent.
[118] P. Grof,et al. Maintenance treatment of adolescent bipolar disorder: open study of the effectiveness and tolerability of quetiapine , 2009, BMC psychiatry.
[119] M. Alda,et al. Antidepressant monotherapy in pre-bipolar depression; predictive value and inherent risk. , 2008, Journal of affective disorders.
[120] J. Sweeney,et al. Effectiveness of lamotrigine in maintaining symptom control in pediatric bipolar disorder. , 2009, Journal of child and adolescent psychopharmacology.
[121] S. Potkin,et al. Intramuscular (IM) ziprasidone 20 mg is effective in reducing acute agitation associated with psychosis: a double-blind, randomized trial , 2001, Psychopharmacology.
[122] D. Luckenbaugh,et al. Efficacy of a protein kinase C inhibitor (tamoxifen) in the treatment of acute mania: a pilot study. , 2007, Bipolar disorders.
[123] C. Mrakotsky,et al. Comparative Clinical Responses to Risperidone and Divalproex in Patients with Pediatric Bipolar Disorder , 2008, Journal of psychiatric practice.
[124] M. Liebowitz,et al. Ziprasidone monotherapy in bipolar II depression: an open trial. , 2009, Journal of affective disorders.
[125] B. Birmaher,et al. Preliminary findings regarding proinflammatory markers and brain-derived neurotrophic factor among adolescents with bipolar spectrum disorders. , 2011, Journal of child and adolescent psychopharmacology.
[126] R. Dittmann,et al. The safety of olanzapine in adolescents with schizophrenia or bipolar I disorder: a pooled analysis of 4 clinical trials. , 2009, The Journal of clinical psychiatry.
[127] M. Thase,et al. Suicide and suicide attempts in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). , 2011, Journal of affective disorders.
[128] J. Calabrese,et al. A double-blind, placebo-controlled study with quetiapine as adjunct therapy with lithium or divalproex in bipolar I patients with coexisting alcohol dependence. , 2010, Alcoholism, clinical and experimental research.
[129] M. Zimmerman,et al. Sustained unemployment in psychiatric outpatients with bipolar disorder: frequency and association with demographic variables and comorbid disorders. , 2010, Bipolar disorders.
[130] S. Strakowski,et al. Twelve-month outcome of adolescents with bipolar disorder following first hospitalization for a manic or mixed episode. , 2007, The American journal of psychiatry.
[131] Y. Joo,et al. Weight change in the acute treatment of bipolar I disorder: a naturalistic observational study of psychiatric inpatients. , 2008, Journal of affective disorders.
[132] C. Faravelli,et al. Health-related quality of life in euthymic bipolar disorder patients: differences between bipolar I and II subtypes. , 2007, The Journal of clinical psychiatry.
[133] M. Sanches,et al. Rapid tranquilization for agitated patients in emergency psychiatric rooms: a randomized trial of olanzapine, ziprasidone, haloperidol plus promethazine, haloperidol plus midazolam and haloperidol alone. , 2011, Revista brasileira de psiquiatria.
[134] H. Blumberg,et al. Levetiracetam in the management of bipolar depression: a randomized, double-blind, placebo-controlled trial. , 2011, The Journal of clinical psychiatry.
[135] K. Kendrick,et al. Quetiapine Augmentation in Lactation: A Series of Case Reports , 2006, Journal of clinical psychopharmacology.
[136] Adam Meyers,et al. An observational study of the effectiveness and safety of intramuscular olanzapine in the treatment of acute agitation in patients with bipolar mania or schizophrenia/schizoaffective disorder , 2007, Human psychopharmacology.
[137] N. Craddock,et al. Early postpartum symptoms in puerperal psychosis , 2008, BJOG : an international journal of obstetrics and gynaecology.
[138] Wilhelmina S Kerstjens-Frederikse,et al. First-trimester use of paroxetine and congenital heart defects: a population-based case-control study. , 2009, Birth defects research. Part A, Clinical and molecular teratology.
[139] Adjunctive lamotrigine therapy for patients with bipolar II depression partially responsive to mood stabilizers , 2010, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[140] J. Azorin,et al. Mixed states vs. pure mania in the french sample of the EMBLEM study: results at baseline and 24 months – European mania in bipolar longitudinal evaluation of medication , 2009, BMC psychiatry.
[141] J. Mann,et al. Treatment of suicide attempters with bipolar disorder: a randomized clinical trial comparing lithium and valproate in the prevention of suicidal behavior. , 2011, The American journal of psychiatry.
[142] E. Vieta,et al. Postpartum bipolar episodes are not distinct from spontaneous episodes: implications for DSM-V. , 2010, Journal of affective disorders.
[143] Y. Bersudsky,et al. Rapid tryptophan depletion as a treatment for acute mania: a double-blind, pilot-controlled study. , 2007, Bipolar disorders.
[144] R. Lam,et al. Divalproex sodium versus placebo in the treatment of acute bipolar depression: a systematic review and meta-analysis. , 2010, Journal of affective disorders.
[145] P. Fitzgerald,et al. A pilot study of hormone modulation as a new treatment for mania in women with bipolar affective disorder , 2006, Psychoneuroendocrinology.
[146] J. Calabrese,et al. Transition to Mania During Treatment of Bipolar Depression , 2010, Neuropsychopharmacology.
[147] L. Citrome,et al. Weight Gain and Changes in Metabolic Variables following Olanzapine Treatment in Schizophrenia and Bipolar Disorder , 2011, Clinical drug investigation.
[148] J. Calabrese,et al. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. , 2003, Archives of general psychiatry.
[149] J. Geddes,et al. Psychosocial interventions for the prevention of relapse in bipolar disorder: systematic review of controlled trials , 2008, British Journal of Psychiatry.
[150] M. Ghadiri,et al. Folic acid efficacy as an alternative drug added to sodium valproate in the treatment of acute phase of mania in bipolar disorder: a double‐blind randomized controlled trial , 2009, Acta psychiatrica Scandinavica.
[151] J. Calabrese,et al. Metabolic syndrome in patients enrolled in a clinical trial of aripiprazole in the maintenance treatment of bipolar I disorder: a post hoc analysis of a randomized, double-blind, placebo-controlled trial. , 2010, The Journal of clinical psychiatry.
[152] Suena H. Massey,et al. Antidepressant-Induced Mania with Concomitant Mood Stabilizer in Patients with Comorbid Substance Abuse and Bipolar Disorder , 2009, Journal of addictive diseases.
[153] Sarah L. Desmarais,et al. Risk of arrest in persons with schizophrenia and bipolar disorder in a Florida Medicaid program: the role of atypical antipsychotics, conventional neuroleptics, and routine outpatient behavioral health services. , 2011, The Journal of clinical psychiatry.
[154] R. Baldessarini,et al. Lamotrigine in bipolar disorder: efficacy during pregnancy. , 2008, Bipolar disorders.
[155] E. Vieta,et al. Group psychoeducation for stabilised bipolar disorders: 5-year outcome of a randomised clinical trial , 2009, British Journal of Psychiatry.
[156] Divalproex extended-release in acute bipolar II depression. , 2010, Journal of affective disorders.
[157] S. Haller,et al. Longitudinal analysis of cognitive performances and structural brain changes in late‐life bipolar disorder , 2011, International journal of geriatric psychiatry.
[158] M. Tohen,et al. Olanzapine versus risperidone in the treatment of manic or mixed States in bipolar I disorder: a randomized, double-blind trial. , 2006, The Journal of clinical psychiatry.
[159] P. Lim,et al. Paliperidone extended-release as adjunctive therapy to lithium or valproate in the treatment of acute mania: a randomized, placebo-controlled study. , 2011, Journal of affective disorders.
[160] J. Culver,et al. Long-term effectiveness of quetiapine in bipolar disorder in a clinical setting. , 2010, Journal of psychiatric research.
[161] T. Suppes,et al. Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers. , 2006, The American journal of psychiatry.
[162] P. Chou,et al. Prevalence of diabetes in patients with bipolar disorder in Taiwan: a population-based national health insurance study. , 2010, General hospital psychiatry.
[163] M. Versavel,et al. Tolerability of oral ziprasidone in children and adolescents with bipolar mania, schizophrenia, or schizoaffective disorder. , 2008, Journal of child and adolescent psychopharmacology.
[164] I. Soreca,et al. Measured and expected resting energy expenditure in patients with bipolar disorder on maintenance treatment. , 2007, Bipolar disorders.
[165] W. Steinmann,et al. Bariatric Surgery: 1-Year Weight Loss Outcomes in Patients with Bipolar and Other Psychiatric Disorders , 2011, Obesity surgery.
[166] A. Young,et al. Aripiprazole monotherapy in acute mania: 12-week randomised placebo- and haloperidol-controlled study , 2009, British Journal of Psychiatry.
[167] R. McIntyre,et al. Bipolar disorder and metabolic syndrome: an international perspective. , 2010, Journal of affective disorders.
[168] K. Soares-Weiser,et al. Pharmacological interventions for the prevention of relapse in bipolar disorder: a systematic review of controlled trials , 2009, Journal of psychopharmacology.
[169] L. Citrome,et al. Impact of real-world ziprasidone dosing on treatment discontinuation rates in patients with schizophrenia or bipolar disorder , 2009, Schizophrenia Research.
[170] Ellen Frank,et al. Psychosocial treatments for bipolar depression: a 1-year randomized trial from the Systematic Treatment Enhancement Program. , 2007, Archives of general psychiatry.
[171] M. Tohen,et al. A Double-Blind, Randomized Comparison of the Efficacy and Safety of Intramuscular Injections of Olanzapine, Lorazepam, or Placebo in Treating Acutely Agitated Patients Diagnosed With Bipolar Mania , 2001, Journal of clinical psychopharmacology.
[172] J. Stewart,et al. Hypomania with and without Dysphoria: comparison of comorbidity and clinical characteristics of respondents from a national community sample. , 2008, Journal of affective disorders.
[173] K. Chang,et al. Early psychosocial intervention for youth at risk for bipolar I or II disorder: a one-year treatment development trial. , 2011, Bipolar disorders.
[174] S. Edwards,et al. Tolerability of atypical antipsychotics in the treatment of adults with schizophrenia or bipolar disorder: a mixed treatment comparison of randomized controlled trials. , 2009, Clinical therapeutics.
[175] C. Nemeroff,et al. Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression. , 2001, The American journal of psychiatry.
[176] J. Mullen,et al. Quetiapine Versus Placebo in Combination With Lithium or Divalproex for the Treatment of Bipolar Mania , 2004, Journal of clinical psychopharmacology.
[177] P. Osváth,et al. Intramuscular olanzapine vs. intramuscular short‐acting antipsychotics: safety, tolerability and the switch to oral antipsychotic medication in patients with schizophrenia or acute mania , 2009, International journal of clinical practice.
[178] F. Baylé,et al. Bipolar disorders and quality of life: The impact of attention deficit/hyperactivity disorder and substance abuse in euthymic patients , 2008, Psychiatry Research.
[179] Verinder Sharma,et al. Screening for bipolar disorder during pregnancy and the postpartum period. , 2010, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.
[180] M. Berk,et al. Selective serotonin reuptake inhibitor use and bone mineral density in women with a history of depression , 2008, International clinical psychopharmacology.
[181] F. McMahon,et al. Linkage of bipolar disorder to chromosome 18q and the validity of bipolar II disorder. , 2001, Archives of general psychiatry.
[182] E. Vieta,et al. Impact of caregiver group psychoeducation on the course and outcome of bipolar patients in remission: a randomized controlled trial. , 2008, Bipolar disorders.
[183] J. Calabrese,et al. A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. , 2005, The American journal of psychiatry.
[184] J. Culver,et al. Adjunctive aripiprazole in treatment-resistant bipolar depression. , 2006, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.
[185] J. Calabrese,et al. Aripiprazole monotherapy for maintenance therapy in bipolar I disorder: a 100-week, double-blind study versus placebo. , 2007, The Journal of clinical psychiatry.
[186] H. Swartz,et al. Psychotherapy as monotherapy for the treatment of bipolar II depression: a proof of concept study. , 2009, Bipolar disorders.
[187] J. Lucey,et al. Intramuscular ziprasidone compared with intramuscular haloperidol in the treatment of acute psychosis. Ziprasidone I.M. Study Group. , 2000, The Journal of clinical psychiatry.
[188] M. Lage,et al. The relationship between antipsychotic medication adherence and patient outcomes among individuals diagnosed with bipolar disorder: a retrospective study , 2009, Annals of general psychiatry.
[189] R. Freire,et al. The effectiveness of cognitive behavioral group therapy in treating bipolar disorder: a randomized controlled study. , 2011, Revista brasileira de psiquiatria.
[190] H. Kyomen. The use of levetiracetam to decrease mania in elderly bipolar patients. , 2006, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[191] R. El-Mallakh,et al. Adverse event load in bipolar participants receiving either carbamazepine immediate-release or extended-release capsules: a blinded, randomized study , 2009, International clinical psychopharmacology.
[192] P. Fitzgerald,et al. Tamoxifen – a potential treatment for women in the manic phase of bipolar affective disorder? , 2006, Acta Neuropsychiatrica.
[193] J. Calabrese,et al. Intensive psychosocial intervention enhances functioning in patients with bipolar depression: results from a 9-month randomized controlled trial. , 2007, The American journal of psychiatry.
[194] U. Albert,et al. Olanzapine or lamotrigine addition to lithium in remitted bipolar disorder patients with anxiety disorder comorbidity: a randomized, single-blind, pilot study. , 2008, The Journal of clinical psychiatry.
[195] E. Vieta,et al. A 6-month, Randomized, Placebo-controlled, Double Blind Trial of Ziprasidone Plus a Mood Stabilizer in Subjects With Bipolar I Disorder , 2009, European Psychiatry.
[196] D. Kupfer,et al. Medical burden in late-life bipolar and major depressive disorders. , 2008, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[197] F. Benazzi. Challenging the unipolar–bipolar division: Does mixed depression bridge the gap? , 2007, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[198] L. Hranov,et al. Efficacy of valproate versus lithium in mania or mixed mania: a randomized, open 12-week trial , 2010, International clinical psychopharmacology.
[199] Hans H Stassen,et al. Clinical value of early partial symptomatic improvement in the prediction of response and remission during short-term treatment trials in 3369 subjects with bipolar I or II depression. , 2011, Journal of affective disorders.
[200] Raminder Kumar. Approved and investigational uses of modafinil : an evidence-based review. , 2008, Drugs.
[201] C. Hertzman,et al. Major congenital malformations following prenatal exposure to serotonin reuptake inhibitors and benzodiazepines using population-based health data. , 2008, Birth defects research. Part B, Developmental and reproductive toxicology.
[202] R. Lam,et al. Course and Outcome after the First Manic Episode in Patients with Bipolar Disorder: Prospective 12-Month Data from the Systematic Treatment Optimization Program for Early Mania Project , 2009, Canadian journal of psychiatry. Revue canadienne de psychiatrie.
[203] A. Nierenberg,et al. Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). , 2006, The American journal of psychiatry.
[204] R. McIntyre,et al. Quetiapine in the treatment of acute bipolar mania: efficacy across a broad range of symptoms. , 2007, Journal of affective disorders.
[205] Joseph R Calabrese,et al. The Texas implementation of medication algorithms: update to the algorithms for treatment of bipolar I disorder. , 2005, The Journal of clinical psychiatry.
[206] M. Tohen,et al. Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study. , 2009, The Journal of clinical psychiatry.
[207] L. Yatham,et al. Risperidone Long-Acting Injectable Monotherapy in the Maintenance Treatment of Bipolar I Disorder , 2010, Biological Psychiatry.
[208] W. Bunn,et al. Indirect Costs Associated With Nonadherence to Treatment for Bipolar Disorder , 2010, Journal of occupational and environmental medicine.
[209] A. Kilbourne,et al. Is the collaborative chronic care model effective for patients with bipolar disorder and co-occurring conditions? , 2009, Journal of affective disorders.
[210] J. Calabrese,et al. A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group. , 1999, The Journal of clinical psychiatry.
[211] R. Shelton,et al. Effects of orally disintegrating vs regular olanzapine tablets on body weight, eating behavior, glycemic and lipid indices, and gastrointestinal hormones: a randomized, open comparison in outpatients with bipolar depression. , 2011, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.
[212] A. Eskild,et al. Use of Psychotropic Medications in Treating Mood Disorders during Lactation , 2006, CNS drugs.
[213] N. Ryan,et al. Clinical and psychosocial correlates of non-suicidal self-injury within a sample of children and adolescents with bipolar disorder. , 2010, Journal of affective disorders.
[214] T. Suppes,et al. Three times more days depressed than manic or hypomanic in both bipolar I and bipolar II disorder. , 2007, Bipolar disorders.
[215] E. Vieta,et al. Assessment of safety, tolerability and effectiveness of adjunctive aripiprazole to lithium/valproate in bipolar mania: a 46-week, open-label extension following a 6-week double-blind study , 2010, Current medical research and opinion.
[216] L. Judd,et al. Psychosocial disability and work role function compared across the long-term course of bipolar I, bipolar II and unipolar major depressive disorders. , 2008, Journal of affective disorders.
[217] Nancy Brahm,et al. Quetiapine for acute mania in bipolar disorder. , 2007, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[218] M. Berk,et al. N-Acetyl Cysteine for Depressive Symptoms in Bipolar Disorder—A Double-Blind Randomized Placebo-Controlled Trial , 2008, Biological Psychiatry.
[219] S. Bolge,et al. Correlates of medication adherence among patients with bipolar disorder: results of the bipolar evaluation of satisfaction and tolerability (BEST) study: a nationwide cross-sectional survey. , 2010, Primary care companion to the Journal of clinical psychiatry.
[220] L. Hynan,et al. A Randomized, Placebo-Controlled Trial of Citicoline Add-On Therapy in Outpatients With Bipolar Disorder and Cocaine Dependence , 2007, Journal of clinical psychopharmacology.
[221] Dost Öngür,et al. Rapid Enhancement of Glutamatergic Neurotransmission in Bipolar Depression Following Treatment with Riluzole , 2010, Neuropsychopharmacology.
[222] J. Rice,et al. Manic/Hypomanic Symptom Burden and Cardiovascular Mortality in Bipolar Disorder , 2009, Psychosomatic medicine.
[223] C. Bowden,et al. Valproate for the treatment of acute bipolar depression: systematic review and meta-analysis. , 2010, Journal of affective disorders.
[224] M. Onofrj,et al. COMT inhibition with tolcapone in the treatment algorithm of patients with Parkinson’s disease (PD): relevance for motor and non-motor features , 2008, Neuropsychiatric disease and treatment.
[225] J. Amsterdam,et al. Venlafaxine versus lithium monotherapy of rapid and non-rapid cycling patients with bipolar II major depressive episode: a randomized, parallel group, open-label trial. , 2009, Journal of affective disorders.
[226] D. Henry,et al. Maintenance model of integrated psychosocial treatment in pediatric bipolar disorder: A pilot feasibility study. , 2007, Journal of the American Academy of Child and Adolescent Psychiatry.
[227] Megan M. Filkowski,et al. Divalproex in the treatment of acute bipolar depression: a preliminary double-blind, randomized, placebo-controlled pilot study. , 2007, The Journal of clinical psychiatry.
[228] Megan M. Filkowski,et al. A Double-Blind, Placebo-Controlled Pilot Study of Galantamine to Improve Cognitive Dysfunction in Minimally Symptomatic Bipolar Disorder , 2009, Journal of clinical psychopharmacology.
[229] C. Datto,et al. Effectiveness of Extended-release Formulation of Quetiapine as Monotherapy for the Treatment of Acute Bipolar Mania (Trial D144CC00004) , 2009, European Psychiatry.
[230] J. Stewart,et al. Efficacy and safety of antidepressant monotherapy in the treatment of bipolar-II depression , 2007, International clinical psychopharmacology.
[231] J. Amsterdam,et al. Olanzapine versus divalproex versus placebo in the treatment of mild to moderate mania: a randomized, 12-week, double-blind study. , 2008, The Journal of clinical psychiatry.
[232] R. Mcquade,et al. Management of Acute Agitation in Patients With Bipolar Disorder: Efficacy and Safety of Intramuscular Aripiprazole , 2007, Journal of clinical psychopharmacology.
[233] B. Mulsant,et al. Depression symptom ratings in geriatric patients with bipolar mania , 2011, International journal of geriatric psychiatry.
[234] J. Rendell,et al. Haloperidol alone or in combination for acute mania. , 2006, The Cochrane database of systematic reviews.
[235] S. Kennedy,et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: update 2007. , 2006, Bipolar disorders.
[236] P. Rocca,et al. Oral risperidone, olanzapine and quetiapine versus haloperidol in psychotic agitation , 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[237] D. Steinwachs,et al. Evaluation of guideline-concordant care for bipolar disorder among privately insured youth. , 2010, Primary care companion to the Journal of clinical psychiatry.
[238] E. Vieta,et al. P.2.e.018 Randomized, placebo, active-controlled study of paliperidone extended-release (ER) for acute manic and mixed episodes in bipolar I disorder , 2008, European Neuropsychopharmacology.
[239] M. De Hert,et al. Prevalence of diabetes and the metabolic syndrome in a sample of patients with bipolar disorder. , 2008, Bipolar disorders.
[240] A. Kilbourne,et al. Improving medical and psychiatric outcomes among individuals with bipolar disorder: a randomized controlled trial. , 2008, Psychiatric services.
[241] Mark A Frye,et al. A placebo-controlled evaluation of adjunctive modafinil in the treatment of bipolar depression. , 2007, The American journal of psychiatry.
[242] J. Geddes,et al. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis , 2009, The Lancet.
[243] S. Akhondzadeh,et al. Double-blind, randomized, placebo-controlled 6-week study on the efficacy and safety of the tamoxifen adjunctive to lithium in acute bipolar mania. , 2011, Journal of affective disorders.
[244] J. Calabrese,et al. Quetiapine and classical mood stabilizers in the long-term treatment of Bipolar Disorder: a 4-year follow-up naturalistic study. , 2008, Journal of affective disorders.
[245] R. Kessler,et al. Major depressive disorder with subthreshold bipolarity in the National Comorbidity Survey Replication. , 2010, The American journal of psychiatry.
[246] P. Bria,et al. Effect of aripiprazole on self-reported anhedonia in bipolar depressed patients , 2009, Psychiatry Research.
[247] M. Brecher,et al. P0114 - Quetiapine in the maintenance treatment of bipolar I disorder: Combined data from two long-term phase III studies , 2008, European Psychiatry.
[248] J. Calabrese,et al. A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group. , 1999, The Journal of clinical psychiatry.
[249] J. Calabrese,et al. Comorbid anxiety and substance use disorders associated with a lower use of mood stabilisers in patients with rapid cycling bipolar disorder: a descriptive analysis of the cross‐sectional data of 566 patients , 2010, International journal of clinical practice.
[250] G. Perugi,et al. The impact of premenstrual dysphoric disorder among 92 bipolar patients , 2010, European Psychiatry.
[251] Lamotrigine plus quetiapine combination therapy in treatment-resistant bipolar depression. , 2011, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.
[252] Comparative efficacy and safety of oxcarbazepine versus divalproex sodium in the treatment of acute mania: A pilot study , 2009, European Psychiatry.
[253] J. Amsterdam,et al. Efficacy and Mood Conversion Rate of Short-Term Fluoxetine Monotherapy of Bipolar II Major Depressive Episode , 2010, Journal of clinical psychopharmacology.
[254] R. Mcquade,et al. Efficacy and safety of aripiprazole in subpopulations with acute manic or mixed episodes of bipolar I disorder. , 2008, Journal of affective disorders.
[255] Shaw-Ji Chen,et al. Concomitant use of lamotrigine and aripiprazole increases risk of Stevens-Johnson syndrome? , 2007, International clinical psychopharmacology.
[256] E. Vieta,et al. P0155 - Maintenance treatment in bipolar I disorder with Quetiapine in combination with Lithium/Divalproex: A placebo-controlled, randomized trial (North American trial D1447C00127) , 2008, European Psychiatry.
[257] P. Renshaw,et al. Protein kinase C inhibition in the treatment of mania: a double-blind, placebo-controlled trial of tamoxifen. , 2008, Archives of general psychiatry.
[258] Amanda T. Woodward,et al. Prevalence and burden of general medical conditions among adults with bipolar I disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions. , 2009, The Journal of clinical psychiatry.
[259] M. Olfson,et al. National trends in the outpatient diagnosis and treatment of bipolar disorder in youth. , 2007, Archives of general psychiatry.
[260] T. Mendelson,et al. Risks and predictors of readmission for a mental disorder during the postpartum period. , 2009, Archives of general psychiatry.
[261] M. Berk,et al. The association between depressive and anxiety symptoms and bone mineral density in the general population: the HUNT Study. , 2011, Journal of affective disorders.
[262] N. Chiu,et al. A single‐blind, comparative study of zotepine versus haloperidol in combination with a mood stabilizer for patients with moderate‐to‐severe mania , 2010, Psychiatry and clinical neurosciences.
[263] J. Martínez-Ortega,et al. Poor adherence to treatment associated with a high recurrence in a bipolar disorder outpatient sample. , 2010, Journal of affective disorders.
[264] G. Perugi,et al. Comparative Response to Electroconvulsive Therapy in Medication-Resistant Bipolar I Patients With Depression and Mixed State , 2010, The journal of ECT.
[265] T. Ketter,et al. Rates of remission/euthymia with quetiapine monotherapy compared with placebo in patients with acute mania. , 2007, Journal of affective disorders.
[266] G. Mazzotti,et al. Outcomes for Latin American Versus White Patients Suffering From Acute Mania in a Randomized, Double-Blind Trial Comparing Olanzapine and Haloperidol , 2007, Journal of clinical psychopharmacology.
[267] R. Hirschfeld,et al. Quetiapine in the treatment of anxiety in patients with bipolar I or II depression: a secondary analysis from a randomized, double-blind, placebo-controlled study. , 2006, The Journal of clinical psychiatry.
[268] Hsiao-ye Yi,et al. Effect of comorbid alcohol and drug use disorders on premature death among unipolar and bipolar disorder decedents in the United States, 1999 to 2006. , 2011, Comprehensive psychiatry.
[269] J. Potash,et al. Reproductive cycle-associated mood symptoms in women with major depression and bipolar disorder. , 2007, Journal of affective disorders.
[270] M. Tohen,et al. Early symptom change and prediction of subsequent remission with olanzapine augmentation in divalproex-resistant bipolar mixed episodes. , 2011, Journal of Psychiatric Research.
[271] J. Calabrese,et al. Medical comorbidity in bipolar disorder: relationship between illnesses of the endocrine/metabolic system and treatment outcome. , 2010, Bipolar disorders.
[272] M. Berk,et al. N-acetyl cysteine add-on treatment for bipolar II disorder: a subgroup analysis of a randomized placebo-controlled trial. , 2011, Journal of affective disorders.
[273] P. Giannakopoulos,et al. Longitudinal assessment of psychotherapeutic day hospital treatment for elderly patients with depression , 2008, International journal of geriatric psychiatry.
[274] T. Treuer,et al. Twelve-month prospective, multinational, observational study of factors associated with recovery from mania in bipolar disorder in patients treated with atypical antipsychotics , 2010, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.
[275] P. Mitchell,et al. A randomized controlled trial of cognitive therapy for bipolar disorder: focus on long-term change. , 2006, The Journal of clinical psychiatry.
[276] D. Cohen,et al. Comorbidity with ADHD Decreases Response to Pharmacotherapy in Children and Adolescents with Acute Mania: Evidence from a Metaanalysis , 2007, Canadian journal of psychiatry. Revue canadienne de psychiatrie.
[277] M. Frye,et al. Comorbid substance use disorder in women with bipolar disorder associated with criminal arrest. , 2007, Bipolar disorders.
[278] J. Litvoc,et al. Comparison of carbamazepine and lithium in treatment of bipolar disorder: A systematic review of randomized controlled trials , 2009, Human psychopharmacology.
[279] M. Tohen,et al. Olanzapine/fluoxetine combination vs. lamotrigine in the 6-month treatment of bipolar I depression. , 2009, The international journal of neuropsychopharmacology.
[280] T. Suppes,et al. Lower switch rate in depressed patients with bipolar II than bipolar I disorder treated adjunctively with second-generation antidepressants. , 2006, The American journal of psychiatry.
[281] E. Vieta,et al. Treatment of psychotic symptoms in bipolar disorder with aripiprazole monotherapy: a meta-analysis , 2010, Annals of General Psychiatry.
[282] R. McIntyre. Understanding needs, interactions, treatment, and expectations among individuals affected by bipolar disorder or schizophrenia: the UNITE global survey. , 2009, The Journal of clinical psychiatry.
[283] J. Amsterdam,et al. Efficacy and safety of long-term fluoxetine versus lithium monotherapy of bipolar II disorder: a randomized, double-blind, placebo-substitution study. , 2010, The American journal of psychiatry.
[284] A. Bartolucci,et al. Divalproex in the treatment of bipolar depression: a placebo-controlled study. , 2005, Journal of affective disorders.
[285] J. Calabrese,et al. Maintenance of response following stabilization of mixed index episodes with olanzapine monotherapy in a randomized, double-blind, placebo-controlled study of bipolar 1 disorder. , 2009, Journal of affective disorders.
[286] P. Kurdyak,et al. Differences in Prevalence and Treatment of Bipolar Disorder among Immigrants: Results from an Epidemiologic Survey , 2009, Canadian journal of psychiatry. Revue canadienne de psychiatrie.
[287] L. Gram,et al. Lamotrigine versus lithium as maintenance treatment in bipolar I disorder: an open, randomized effectiveness study mimicking clinical practice. The 6th trial of the Danish University Antidepressant Group (DUAG-6). , 2010, Bipolar disorders.
[288] E. Vieta,et al. Amisulpride plus valproate vs haloperidol plus valproate in the treatment of acute mania of bipolar I patients: a multicenter, open-label, randomized, comparative trial , 2008, Neuropsychiatric disease and treatment.
[289] R. McIntyre,et al. A 3-week, randomized, placebo-controlled trial of asenapine in the treatment of acute mania in bipolar mania and mixed states. , 2009, Bipolar disorders.
[290] J. McClellan,et al. Interpersonal and social rhythm therapy for adolescents with bipolar disorder: treatment development and results from an open trial , 2010, Depression and anxiety.
[291] A. Kilbourne,et al. Therapeutic drug and cardiovascular disease risk monitoring in patients with bipolar disorder. , 2007, Journal of affective disorders.
[292] Verinder Sharma. A cautionary note on the use of antidepressants in postpartum depression. , 2006, Bipolar disorders.
[293] L. Sirota,et al. Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants. , 2006, Archives of pediatrics & adolescent medicine.
[294] M. Monuteaux,et al. A controlled family study of children with DSM-IV bipolar-I disorder and psychiatric co-morbidity , 2009, Psychological Medicine.
[295] P. Keck,et al. Placebo-controlled study of quetiapine monotherapy in ambulatory bipolar spectrum disorder with moderate-to-severe hypomania or mild mania. , 2010, Journal of affective disorders.
[296] S. Strakowski,et al. A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania. , 2002, Journal of the American Academy of Child and Adolescent Psychiatry.
[297] S. Hernández-Díaz,et al. Selective Serotonin-Reuptake Inhibitors and Risk of Persistent Pulmonary Hypertension of the Newborn , 2006, The New England journal of medicine.
[298] N. Craddock,et al. A longitudinal study of hypomania and depression symptoms in pregnancy and the postpartum period. , 2009, Bipolar disorders.
[299] Minoru Takeshima,et al. Impact of depressive mixed state in an emergency psychiatry setting: a marker of bipolar disorder and a possible risk factor for emergency hospitalization. , 2008, Journal of affective disorders.
[300] H. Calil,et al. Family interventions for bipolar disorder. , 2007, The Cochrane database of systematic reviews.
[301] L. Rohde,et al. Aripiprazole in children and adolescents with bipolar disorder comorbid with attention-deficit/hyperactivity disorder: a pilot randomized clinical trial. , 2009, The Journal of clinical psychiatry.
[302] R. Kessler,et al. Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. , 2011, Archives of general psychiatry.
[303] M. Versavel,et al. Ziprasidone plus a mood stabilizer in subjects with bipolar I disorder: a 6-month, randomized, placebo-controlled, double-blind trial. , 2010, The Journal of clinical psychiatry.
[304] R. Baldessarini,et al. Illness risk following rapid versus gradual discontinuation of antidepressants. , 2010, The American journal of psychiatry.
[305] G. Alexopoulos,et al. Age and ratings of manic psychopathology. , 2007, Bipolar disorders.
[306] A. Tripathi,et al. Rapid quetiapine loading in youths with bipolar disorder. , 2010, Journal of child and adolescent psychopharmacology.
[307] Richard A. Mason,et al. Selective Deficit of Autobiographical Incident Memory in Subjects with Bipolar Disorder , 2009, Psychopathology.
[308] J. Zajecka,et al. Intramuscular ziprasidone, 2 mg versus 10 mg, in the short-term management of agitated psychotic patients. , 2001, The Journal of clinical psychiatry.
[309] M. Alda,et al. Can body mass index help predict outcome in patients with bipolar disorder? , 2009, Bipolar disorders.
[310] R. Morriss,et al. Early warning signs checklists for relapse in bipolar depression and mania: utility, reliability and validity. , 2011, Journal of affective disorders.
[311] D. Miklowitz,et al. Family-focused treatment for caregivers of patients with bipolar disorder. , 2010, Bipolar disorders.
[312] B. Dow,et al. 148th Annual Meeting of the American Psychiatric Association , 1996 .
[313] C. Born,et al. Mirtazapine monotherapy versus combination therapy with mirtazapine and aripiprazole in depressed patients without psychotic features: A 4-week open-label parallel-group study , 2007, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.
[314] J. Calabrese,et al. Double-blind, placebo-controlled trial of divalproex monotherapy in the treatment of symptomatic youth at high risk for developing bipolar disorder. , 2007, The Journal of clinical psychiatry.
[315] P. Liddle,et al. Mild Hypomania (the Highs) can be a Feature of the First Postpartum Week , 1994, British Journal of Psychiatry.
[316] M. Provencher,et al. Psychotherapies for comorbid anxiety in bipolar spectrum disorders. , 2011, Journal of affective disorders.
[317] B. Mulsant,et al. Multisite, open‐label, prospective trial of lamotrigine for geriatric bipolar depression: a preliminary report , 2011, Bipolar disorders.
[318] G. Sachs,et al. Efficacy and safety of adjunctive oral ziprasidone for acute treatment of depression in patients with bipolar I disorder: a randomized, double-blind, placebo-controlled trial. , 2011, Journal of Clinical Psychiatry.
[319] Verinder Sharma,et al. Screening for postpartum bipolar disorder: validation of the Mood Disorder Questionnaire. , 2011, Journal of affective disorders.
[320] H. Ascher-Svanum,et al. Costs associated with attempted suicide among individuals with bipolar disorder. , 2010, The journal of mental health policy and economics.
[321] F. Dickerson,et al. Quality of life in individuals with serious mental illness and type 2 diabetes. , 2008, Psychosomatics.
[322] T. Kelly. Is donepezil useful for improving cognitive dysfunction in bipolar disorder? , 2008, Journal of affective disorders.
[323] G. Sachs,et al. Antimanic response to aripiprazole in bipolar I disorder patients is independent of the agitation level at baseline. , 2007, The Journal of clinical psychiatry.
[324] R. Hirschfeld,et al. Asenapine in the treatment of acute mania in bipolar I disorder: Outcomes from two randomized and placebo-controlled trials , 2008 .
[325] J. Calabrese,et al. Relationship of open acute mania treatment to blinded maintenance outcome in bipolar I disorder. , 2008, Journal of affective disorders.
[326] I. Ferrier,et al. The International Society for Bipolar Disorders (ISBD) consensus guidelines for the safety monitoring of bipolar disorder treatments. , 2009, Bipolar disorders.
[327] G. Currier,et al. Acute treatment of psychotic agitation: a randomized comparison of oral treatment with risperidone and lorazepam versus intramuscular treatment with haloperidol and lorazepam. , 2004, The Journal of clinical psychiatry.
[328] C. Blanco,et al. The burden of obesity among adults with bipolar disorder in the United States , 2011, Bipolar disorders.
[329] J. Soares,et al. A double-blind, randomized, placebo-controlled 4-week study on the efficacy and safety of the purinergic agents allopurinol and dipyridamole adjunctive to lithium in acute bipolar mania. , 2008, The Journal of clinical psychiatry.
[330] S. Parikh,et al. Is Cognitive-Behavioural Therapy More Effective Than Psychoeducation in Bipolar Disorder? , 2008, Canadian journal of psychiatry. Revue canadienne de psychiatrie.
[331] T. Ha,et al. Feasibility of a slower lamotrigine titration schedule for bipolar depression: a naturalistic study , 2009, International clinical psychopharmacology.
[332] M. Alda,et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies. , 2005, Bipolar disorders.
[333] J. Amsterdam,et al. Venlafaxine monotherapy in bipolar type II depressed patients unresponsive to prior lithium monotherapy , 2010, Acta psychiatrica Scandinavica.
[334] T. Suppes,et al. Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126). , 2008, Journal of affective disorders.
[335] G. Chouinard,et al. A double-blind randomized clinical trial of rapid tranquilization with I.M. clonazepam and I.M. haloperidol in agitated psychotic patients with manic symptoms. , 1993, Canadian journal of psychiatry. Revue canadienne de psychiatrie.
[336] T. Suppes,et al. Prevalence and correlates of eating disorders in 875 patients with bipolar disorder. , 2011, Journal of affective disorders.
[337] J. Hennen,et al. Adherence to pharmacotherapy in bipolar disorder patients with and without co-occurring substance use disorders. , 2007, The Journal of clinical psychiatry.
[338] J. Sweeney,et al. A comparison of neuropsychological dysfunction in first-episode psychosis patients with unipolar depression, bipolar disorder, and schizophrenia , 2009, Schizophrenia Research.
[339] C. Kuo,et al. Cognitive dysfunction and medical morbidity in elderly outpatients with bipolar disorder. , 2009, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[340] J. Cairney,et al. Comparison of antidepressant use between subjects with bipolar disorder and major depressive disorder with or without comorbid anxiety. , 2007, The Journal of clinical psychiatry.
[341] J. Haro,et al. 2-year course of bipolar disorder type I patients in outpatient care: Factors associated with remission and functional recovery , 2011, European Neuropsychopharmacology.
[342] T. Carmody,et al. A randomized, double-blind, placebo-controlled add-on trial of quetiapine in outpatients with bipolar disorder and alcohol use disorders. , 2008, The Journal of clinical psychiatry.
[343] Verinder Sharma,et al. Bipolar II postpartum depression: Detection, diagnosis, and treatment. , 2009, The American journal of psychiatry.
[344] T. Suppes,et al. Bipolar II disorder: arguments for and against a distinct diagnostic entity. , 2008, Bipolar Disorders.
[345] J. Calabrese,et al. Antipsychotic-Induced Extrapyramidal Side Effects in Bipolar Disorder and Schizophrenia: A Systematic Review , 2008, Journal of clinical psychopharmacology.
[346] M. Tohen,et al. Olanzapine plus carbamazepine v. carbamazepine alone in treating manic episodes , 2008, British Journal of Psychiatry.
[347] B. Birmaher,et al. Dialectical behavior therapy for adolescents with bipolar disorder: a 1-year open trial. , 2007, Journal of the American Academy of Child and Adolescent Psychiatry.
[348] M. Lage,et al. Risk of rehospitalization among bipolar disorder patients who are nonadherent to antipsychotic therapy after hospital discharge. , 2009, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[349] Rash in adult patients receiving lamotrigine to treat bipolar I disorder in Korea: A multicenter, prospective, naturalistic, open-label trial , 2009, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[350] R. Lydiard,et al. Quetiapine monotherapy as treatment for anxiety symptoms in patients with bipolar depression: a pooled analysis of results from 2 double-blind, randomized, placebo-controlled studies. , 2009, Primary care companion to the Journal of clinical psychiatry.
[351] H. Swartz,et al. Suicide attempts in bipolar I and bipolar II disorder: a review and meta-analysis of the evidence. , 2010, Bipolar disorders.
[352] J. Ballenger. Response to ECT in bipolar I, bipolar II and unipolar depression , 2011 .
[353] M. Zimmerman,et al. Psychosocial impairment associated with bipolar II disorder. , 2007, Journal of affective disorders.
[354] T. Johnson,et al. Cognitive-behavioural therapy for bipolar disorder , 2006, British Journal of Psychiatry.
[355] R. Callaghan,et al. The incidence of cardiovascular morbidity among patients with bipolar disorder: a population-based longitudinal study in Ontario, Canada. , 2010, Journal of affective disorders.
[356] C. Nemeroff,et al. Atypical antipsychotic administration during late pregnancy: placental passage and obstetrical outcomes. , 2007, The American journal of psychiatry.
[357] P. McKenna,et al. Cognitive behavioural therapy for major psychiatric disorder: does it really work? A meta-analytical review of well-controlled trials , 2009, Psychological Medicine.
[358] R. Shelton,et al. Risperidone and paroxetine given singly and in combination for bipolar depression. , 2004, The Journal of clinical psychiatry.
[359] B. Birmaher,et al. Pediatric bipolar disorder: validity, phenomenology, and recommendations for diagnosis. , 2008, Bipolar disorders.
[360] Raphael T. Gerraty,et al. A meta-analytic investigation of neurocognitive deficits in bipolar illness: profile and effects of clinical state. , 2009, Neuropsychology.
[361] O. Forlenza,et al. Language impairment in euthymic, elderly patients with bipolar disorder but no dementia , 2008, International Psychogeriatrics.
[362] K. Sokolski. Adjunctive Aripiprazole in Bipolar I Depression , 2007, The Annals of pharmacotherapy.
[363] E. Vieta,et al. Efficacy of modern antipsychotics in placebo-controlled trials in bipolar depression: a meta-analysis. , 2010, The international journal of neuropsychopharmacology.
[364] E. Vieta,et al. Psychoeducation for bipolar II disorder: an exploratory, 5-year outcome subanalysis. , 2009, Journal of affective disorders.
[365] J. Calabrese,et al. Evaluation and comparison of psychometric instruments for pediatric bipolar spectrum disorders in four age groups. , 2007, Journal of child and adolescent psychopharmacology.
[366] P. Buckley,et al. Risk of Neuroleptic Malignant Syndrome in Patients with Bipolar Disorder: A Retrospective, Population-Based Case-Control Study , 2009, International journal of psychiatry in medicine.
[367] E. Vieta,et al. Effectiveness of psychotropic medications in the maintenance phase of bipolar disorder: a meta-analysis of randomized controlled trials. , 2011, The international journal of neuropsychopharmacology.
[368] P. Keck,et al. Memantine Efficacy and Safety in Patients With Acute Mania Associated With Bipolar I Disorder: A Pilot Evaluation , 2009, Clinical neuropharmacology.
[369] A. Kilbourne,et al. Enhancing multiyear guideline concordance for bipolar disorder through collaborative care. , 2009, The American journal of psychiatry.
[370] E. Vieta,et al. P.3.c.058 Efficacy and safety of quetiapine in combination with lithium/divalproex as maintenance treatment for bipolar I disorder , 2007, European Neuropsychopharmacology.
[371] P. Kurdyak,et al. Bipolar disorder among adolescents and young adults: results from an epidemiological sample. , 2010, Journal of affective disorders.
[372] G. Goodwin,et al. Mindfulness-based Cognitive Therapy (MBCT) in bipolar disorder: Preliminary evaluation of immediate effects on between-episode functioning , 2008, Journal of affective disorders.
[373] R. Lam,et al. Weight gain, obesity, and metabolic indices following a first manic episode: prospective 12-month data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM). , 2010, Journal of affective disorders.
[374] R. McIntyre,et al. Quetiapine or haloperidol as monotherapy for bipolar mania—a 12-week, double-blind, randomised, parallel-group, placebo-controlled trial , 2005, European Neuropsychopharmacology.
[375] J. Haro,et al. Effectiveness of olanzapine monotherapy and olanzapine combination treatment in the long term following acute mania--results of a two year observational study in bipolar disorder (EMBLEM). , 2011, Journal of affective disorders.
[376] S. Hernández-Díaz,et al. First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects. , 2007, The New England journal of medicine.
[377] M. Sajatovic,et al. Association between antipsychotic combination therapy and treatment adherence among individuals with bipolar disorder. , 2009, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.
[378] M. Alda,et al. Influence of atypical features on the quality of prophylactic effectiveness of long-term lithium treatment in bipolar disorders. , 2010, Bipolar disorders.
[379] B. Lafer,et al. Clinical significance of lifetime panic disorder in the course of bipolar disorder type I. , 2009, Comprehensive psychiatry.
[380] J. Haro,et al. Assessment of Medication Adherence in a Cohort of Patients with Bipolar Disorder , 2010, Pharmacopsychiatry.
[381] N. Ryan,et al. Preliminary findings regarding overweight and obesity in pediatric bipolar disorder. , 2008, The Journal of clinical psychiatry.
[382] R. Morriss. Implementing clinical guidelines for bipolar disorder. , 2008, Psychology and psychotherapy.
[383] M. Bourin,et al. Effectiveness of aripiprazole v. haloperidol in acute bipolar mania: double-blind, randomised, comparative 12-week trial. , 2005, The British journal of psychiatry : the journal of mental science.
[384] C. Gullion,et al. Randomized Effectiveness Trial of an Internet, Pure Self-Help, Cognitive Behavioral Intervention for Depressive Symptoms in Young Adults , 2009, Cognitive behaviour therapy.
[385] J. Nurnberger,et al. Cannabis involvement in individuals with bipolar disorder , 2011, Psychiatry Research.
[386] W. Nolen,et al. Efficacy and safety of two treatment algorithms in bipolar depression consisting of a combination of lithium, lamotrigine or placebo and paroxetine , 2010, Acta psychiatrica Scandinavica.
[387] A. Ornoy,et al. The outcome of pregnancy following topiramate treatment: a study on 52 pregnancies. , 2008, Reproductive toxicology.
[388] G. Goodwin,et al. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial , 2010, The Lancet.
[389] J. Sweeney,et al. Enhanced working and verbal memory after lamotrigine treatment in pediatric bipolar disorder. , 2010, Bipolar disorders.
[390] P. Falkai,et al. Neurocognitive functions in euthymic bipolar patients , 2009, Acta psychiatrica Scandinavica.
[391] R. Baldessarini,et al. Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation. , 2007, The American journal of psychiatry.
[392] J. Thirthalli,et al. Comparison of electroconvulsive therapy (ECT) with or without anti-epileptic drugs in bipolar disorder. , 2010, Journal of affective disorders.
[393] I. Iancu,et al. Lithium therapy for unipolar and bipolar depression among the middle‐aged and older adult patient subpopulation , 2007, Depression and anxiety.
[394] O. Andreassen,et al. Neurocognitive profiles in bipolar I and bipolar II disorder: differences in pattern and magnitude of dysfunction. , 2008, Bipolar disorders.
[395] R. McIntyre,et al. A cohort study of the prevalence and impact of comorbid medical conditions in pediatric bipolar disorder. , 2010, The Journal of clinical psychiatry.
[396] R. Fieve,et al. Continuation versus discontinuation of lithium in recurrent bipolar illness: a naturalistic study. , 2007, Bipolar disorders.
[397] P. Girardi,et al. Psychotic versus non-psychotic bipolar II disorder. , 2010, Journal of affective disorders.
[398] M. Cunnington. The International Lamotrigine Pregnancy Registry Update for the Epilepsy Foundation , 2004, Epilepsia.
[399] L. Tondo,et al. Effectiveness of Maintenance Electroconvulsive Therapy in Rapid-Cycling Bipolar Disorder , 2011, The journal of ECT.
[400] T. Suppes,et al. Open-label aripiprazole in the treatment of acute bipolar depression: a prospective pilot trial. , 2007, Journal of affective disorders.
[401] K. Shulman,et al. Comorbidity in bipolar disorder among the elderly: results from an epidemiological community sample. , 2006, The American journal of psychiatry.
[402] V. Cornelius,et al. Acute bipolar mania: a systematic review and meta‐analysis of co‐therapy vs. monotherapy , 2007, Acta psychiatrica Scandinavica.
[403] J. Kwon,et al. Association of seasonality and premenstrual symptoms in bipolar I and bipolar II disorders. , 2011, Journal of affective disorders.
[404] D. Kupfer,et al. Cognitive functioning and instrumental activities of daily living in late-life bipolar disorder. , 2007 .
[405] P. Mitchell,et al. Diagnostic guidelines for bipolar disorder: a summary of the International Society for Bipolar Disorders Diagnostic Guidelines Task Force Report. , 2008, Bipolar disorders.
[406] Eduard Vieta,et al. A randomized trial comparing paroxetine and venlafaxine in the treatment of bipolar depressed patients taking mood stabilizers. , 2002, The Journal of clinical psychiatry.
[407] H. Savaş,et al. Atypical Antipsychotic Usage-Related Higher Serum Leptin Levels and Disabled Lipid Profiles in Euthymic Bipolar Patients , 2006, Neuropsychobiology.
[408] P R Williamson,et al. Interventions for helping people recognise early signs of recurrence in bipolar disorder. , 2007, The Cochrane database of systematic reviews.
[409] Hsin-Chien Lee,et al. Cognitive impairment in later life in patients with early-onset bipolar disorder. , 2007, Bipolar disorders.
[410] Emily C. Bell,et al. Neurobiological Findings in Bipolar II Disorder Compared with Findings in Bipolar I Disorder , 2004, Canadian journal of psychiatry. Revue canadienne de psychiatrie.
[411] Preben Bo Mortensen,et al. Absolute risk of suicide after first hospital contact in mental disorder. , 2011, Archives of general psychiatry.
[412] E. Vieta,et al. A long-term prospective study on the outcome of bipolar patients treated with long-acting injectable risperidone , 2008, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.
[413] R. McIntyre,et al. Asenapine versus olanzapine in acute mania: a double-blind extension study. , 2009, Bipolar disorders.
[414] T. Suppes,et al. Tranylcypromine vs. lamotrigine in the treatment of refractory bipolar depression: a failed but clinically useful study , 2007, Acta psychiatrica Scandinavica.
[415] S. McElroy,et al. Awareness of metabolic concerns and perceived impact of pharmacotherapy in patients with bipolar disorder: a survey of 500 US psychiatrists. , 2007, Psychopharmacology bulletin.
[416] J. Walkup. Practice parameter on the use of psychotropic medication in children and adolescents. , 2009, Journal of the American Academy of Child and Adolescent Psychiatry.
[417] R. Kessler,et al. Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. , 2007, Archives of general psychiatry.
[418] F. Kapczinski,et al. Correlation between drug treatment adherence and lithium treatment attitudes and knowledge by bipolar patients , 2007, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[419] J. Calabrese,et al. Efficacy of Quetiapine Monotherapy in Bipolar I and II Depression: A Double-blind, Placebo-controlled Study (The BOLDER II Study) , 2006, Journal of clinical psychopharmacology.
[420] A. Nierenberg,et al. Longitudinal follow-up of bipolar disorder in women with premenstrual exacerbation: findings from STEP-BD. , 2011, The American journal of psychiatry.
[421] M. Tohen,et al. Olanzapine versus placebo in the treatment of adolescents with bipolar mania. , 2007, The American journal of psychiatry.
[422] T. Carmody,et al. A randomized, double-blind, placebo-controlled pilot study of naltrexone in outpatients with bipolar disorder and alcohol dependence. , 2009, Alcoholism, clinical and experimental research.
[423] R. McIntyre,et al. Asenapine in the treatment of acute mania in bipolar I disorder: a randomized, double-blind, placebo-controlled trial. , 2010, Journal of affective disorders.
[424] R. Hirschfeld,et al. A randomized, placebo-controlled, multicenter study of divalproex sodium extended-release in the acute treatment of mania. , 2010, The Journal of clinical psychiatry.
[425] G. Dunn,et al. A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder. , 2007, Health technology assessment.
[426] B. Mulsant,et al. A 12‐week open‐label pilot study of donepezil for cognitive functioning and instrumental activities of daily living in late‐life bipolar disorder , 2008, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[427] P. Keck,et al. Long-term safety and efficacy of ziprasidone in subpopulations of patients with bipolar mania. , 2009, The Journal of clinical psychiatry.
[428] R. Lam,et al. The association of weight gain with mood symptoms and functional outcomes following a first manic episode: prospective 12-month data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM). , 2010, Bipolar disorders.
[429] H. Akiskal,et al. Role of risperidone in bipolar II: an open 6-month study. , 2001, Journal of affective disorders.
[430] Virgil L. Gregory. Cognitive-Behavioral Therapy for Depression in Bipolar Disorder: A Meta-Analysis , 2010, Journal of evidence-based social work.
[431] S. Strakowski,et al. A double-blind randomized pilot study comparing quetiapine and divalproex for adolescent mania. , 2006, Journal of the American Academy of Child and Adolescent Psychiatry.
[432] K. Demyttenaere,et al. Ultra-brief pulse ECT in bipolar and unipolar depressive disorder: differences in speed of response. , 2009, Bipolar disorders.
[433] R. Shelton,et al. Olanzapine monotherapy for acute depression in patients with bipolar I or II disorder: results of an 8‐week open label trial , 2010, Human psychopharmacology.
[434] A. Young,et al. A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II). , 2010, The Journal of clinical psychiatry.
[435] J. Calabrese,et al. Acute efficacy of divalproex sodium versus placebo in mood stabilizer-naive bipolar I or II depression: a double-blind, randomized, placebo-controlled trial. , 2011, The Journal of clinical psychiatry.
[436] A. Szegedi,et al. Effects of asenapine on depressive symptoms in patients with bipolar I disorder experiencing acute manic or mixed episodes: a post hoc analysis of two 3-week clinical trials , 2011, BMC psychiatry.
[437] R. Baldessarini,et al. Patterns of psychotropic drug prescription for U.S. patients with diagnoses of bipolar disorders. , 2007, Psychiatric services.
[438] T. Einarson,et al. Incidence of Major Malformations in Infants following Antidepressant Exposure in Pregnancy: Results of a Large Prospective Cohort Study , 2009, Canadian journal of psychiatry. Revue canadienne de psychiatrie.
[439] P. Keck,et al. Comorbidity of fibromyalgia and psychiatric disorders. , 2006, The Journal of clinical psychiatry.
[440] Verinder Sharma,et al. Missed bipolarity and psychiatric comorbidity in women with postpartum depression. , 2008, Bipolar disorders.
[441] J. Calabrese,et al. Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials , 2009, British Journal of Psychiatry.
[442] P. Sham,et al. A randomized controlled study of cognitive therapy for relapse prevention for bipolar affective disorder: outcome of the first year. , 2003, Archives of general psychiatry.
[443] W. Nolen,et al. Bipolar disorder in the elderly; different effects of age and of age of onset. , 2009, Journal of affective disorders.
[444] W. Milano,et al. Appropriate intervention strategies for weight gain induced by olanzapine: A randomized controlled study , 2007, Advances in therapy.
[445] J. Calabrese,et al. Medical and substance use comorbidity in bipolar disorder. , 2009, Journal of affective disorders.
[446] M. Berk,et al. Do we need to flick the switch? The need for a broader conceptualization of iatrogenic course aggravation in clinical trials of bipolar disorder , 2010, Psychiatry and clinical neurosciences.
[447] A. Kilbourne,et al. Predictors of nonadherence among individuals with bipolar disorder receiving treatment in a community mental health clinic. , 2009, Comprehensive psychiatry.
[448] R. Lam,et al. Antidepressant-associated mood elevations in bipolar II disorder compared with bipolar I disorder and major depressive disorder: a systematic review and meta-analysis. , 2008, The Journal of clinical psychiatry.
[449] I. Bernstein,et al. A single blind comparison of lithium and lamotrigine for the treatment of bipolar II depression. , 2008, Journal of affective disorders.
[450] Rebecca Tillman,et al. Child bipolar I disorder: prospective continuity with adult bipolar I disorder; characteristics of second and third episodes; predictors of 8-year outcome. , 2008, Archives of general psychiatry.
[451] E. Vieta,et al. Work impairment in bipolar disorder patients – results from a two-year observational study (EMBLEM) , 2010, European Psychiatry.
[452] R. Hou,et al. Do treatment and illness beliefs influence adherence to medication in patients with bipolar affective disorder? A preliminary cross-sectional study , 2010, European Psychiatry.
[453] N. Craddock,et al. Developing an online psychoeducation package for bipolar disorder , 2011, Journal of mental health.
[454] J. Biederman,et al. Psychosocial functioning, familiality, and psychiatric comorbidity in bipolar youth with and without psychotic features. , 2011, The Journal of clinical psychiatry.
[455] L. Davis,et al. A pharmacokinetic and clinical evaluation of switching patients with bipolar I disorder from delayed-release to extended-release divalproex. , 2007, The Journal of clinical psychiatry.
[456] N. Ryan,et al. Comparison of manic and depressive symptoms between children and adolescents with bipolar spectrum disorders. , 2009, Bipolar disorders.
[457] J. García-Campayo,et al. A double-blind, randomized, placebo-controlled prophylaxis trial of oxcarbazepine as adjunctive treatment to lithium in the long-term treatment of bipolar I and II disorder. , 2008, The international journal of neuropsychopharmacology.
[458] L. Alphs,et al. P.3.c.066 Adjunctive long-acting risperidone delays mood episode relapse in patients with frequently relapsing bipolar disorder , 2008, European Neuropsychopharmacology.
[459] C. Depp,et al. Assessment of Medication Management Ability in Middle-Aged and Older Adults With Bipolar Disorder , 2008, Journal of clinical psychopharmacology.
[460] M. Clementi,et al. Paroxetine and fluoxetine in pregnancy: a prospective, multicentre, controlled, observational study. , 2008, British journal of clinical pharmacology.
[461] S. Strakowski,et al. Safety and tolerability of quetiapine in the treatment of acute mania in bipolar disorder. , 2007, Journal of affective disorders.
[462] M. Sajatovic,et al. Aripiprazole therapy in 20 older adults with bipolar disorder: a 12-week, open-label trial. , 2008, The Journal of clinical psychiatry.
[463] S. Leucht,et al. Second-generation antipsychotic agents in the treatment of acute mania: a systematic review and meta-analysis of randomized controlled trials. , 2007, Archives of general psychiatry.
[464] M. Tohen,et al. Going up in smoke: tobacco smoking is associated with worse treatment outcomes in mania. , 2008, Journal of affective disorders.
[465] S. Hernández-Díaz,et al. First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects. , 2007, The New England journal of medicine.
[466] Verinder Sharma,et al. Misdiagnosis of bipolar disorder as borderline personality disorder: clinical and economic consequences , 2009, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.
[467] D. Piskulić,et al. A brief dyadic group based psychoeducation program improves relapse rates in recently remitted bipolar disorder: a pilot randomised controlled trial. , 2010, Journal of affective disorders.
[468] J. Gaab,et al. Effects of a multimodal lifestyle intervention on body mass index in patients with bipolar disorder: a randomized controlled trial. , 2010, Primary care companion to the Journal of clinical psychiatry.
[469] Andrew C Leon,et al. Longitudinal course of bipolar I disorder: duration of mood episodes. , 2010, Archives of general psychiatry.
[470] J. Quintero,et al. [Diagnostic errors and temporal stability in bipolar disorder]. , 2008, Actas espanolas de psiquiatria.
[471] C. Blanco,et al. Increased risk for suicidal behavior in comorbid bipolar disorder and alcohol use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). , 2010, The Journal of clinical psychiatry.
[472] F. Benazzi. Bipolar II Disorder , 2007, CNS drugs.
[473] G. Simpson,et al. Efficacy of lorazepam and haloperidol for rapid tranquilization in a psychiatric emergency room setting , 1997, International clinical psychopharmacology.
[474] J. McClellan,et al. Practice parameter for the assessment and treatment of children and adolescents with bipolar disorder. , 2007, Journal of the American Academy of Child and Adolescent Psychiatry.
[475] A. Cavanna,et al. On the prevalence of bipolar disorder in epilepsy , 2008, Epilepsy & Behavior.
[476] A. Serretti,et al. Clinical features, response to treatment and functional outcome of bipolar disorder patients with and without co-occurring substance use disorder: 1-year follow-up. , 2009, Journal of affective disorders.
[477] C. Mathers,et al. Global burden of disease in young people aged 10–24 years: a systematic analysis , 2011, The Lancet.
[478] W. Nolen,et al. Long-term outcome of bipolar depressed patients receiving lamotrigine as add-on to lithium with the possibility of the addition of paroxetine in nonresponders: a randomized, placebo-controlled trial with a novel design. , 2011, Bipolar disorders.
[479] D. Lara,et al. Low-dose quetiapine for patients with dysregulation of hyperthymic and cyclothymic temperaments , 2010, Journal of psychopharmacology.
[480] P. Mcelhatton,et al. Birth weight of infants after maternal exposure to typical and atypical antipsychotics: Prospective comparison study , 2008, British Journal of Psychiatry.
[481] C. Gau,et al. The Association Between Carbamazepine and Valproate and Adverse Cutaneous Drug Reactions in Patients With Bipolar Disorder: A Nested Matched Case-Control Study , 2008, Journal of clinical psychopharmacology.
[482] N. Craddock,et al. Postnatal euphoria: are 'the highs' an indicator of bipolarity? , 2005, Bipolar disorders.
[483] J. Amsterdam,et al. Comparison of Short-Term Venlafaxine Versus Lithium Monotherapy for Bipolar II Major Depressive Episode: A Randomized Open-Label Study , 2008, Journal of clinical psychopharmacology.
[484] M. Husain,et al. Electroconvulsive therapy is equally effective in unipolar and bipolar depression , 2009, Acta psychiatrica Scandinavica.
[485] J. Calabrese,et al. Lamotrigine in the acute treatment of bipolar depression: results of five double-blind, placebo-controlled clinical trials. , 2008, Bipolar disorders.
[486] Rebecca Tillman,et al. Pharmacological and non-drug treatment of child bipolar I disorder during prospective eight-year follow-up. , 2010, Bipolar disorders.
[487] G. Murray,et al. Group-based psychosocial intervention for bipolar disorder: randomised controlled trial , 2010, British Journal of Psychiatry.
[488] H. Grunze,et al. A 12-week, open, randomized trial comparing sodium valproate to lithium in patients with bipolar I disorder suffering from a manic episode , 2008, International clinical psychopharmacology.
[489] A. Kilbourne,et al. Anticonvulsant use, bipolar disorder, and risk of fracture among older adults in the Veterans Health Administration. , 2010, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[490] P. Moberg,et al. The relationship of bipolar disorder lifetime duration and vascular burden to cognition in older adults. , 2010, Bipolar disorders.
[491] M. Fristad. Psychoeducational treatment for school-aged children with bipolar disorder , 2006, Development and Psychopathology.
[492] T. Craig,et al. Self-esteem in remitted bipolar disorder patients: a meta-analysis. , 2010, Bipolar disorders.
[493] Megan M. Filkowski,et al. Antidepressant discontinuation in bipolar depression: a Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) randomized clinical trial of long-term effectiveness and safety. , 2010, The Journal of clinical psychiatry.
[494] J. Calabrese,et al. Adjunctive armodafinil for major depressive episodes associated with bipolar I disorder: a randomized, multicenter, double-blind, placebo-controlled, proof-of-concept study. , 2010, The Journal of clinical psychiatry.
[495] A. Young,et al. Effectiveness of mood stabilizers and antipsychotics in the maintenance phase of bipolar disorder: a systematic review of randomized controlled trials. , 2007, Bipolar disorders.
[496] S. Akhondzadeh,et al. Allopurinol as an adjunct to lithium and haloperidol for treatment of patients with acute mania: a double-blind, randomized, placebo-controlled trial. , 2006, Bipolar disorders.
[497] T. Wilens,et al. A double-blind, randomized, placebo-controlled trial of oxcarbazepine in the treatment of bipolar disorder in children and adolescents. , 2006, The American journal of psychiatry.
[498] J. Alexander,et al. Effects of stimulus intensity on the efficacy and safety of twice-weekly, bilateral electroconvulsive therapy (ECT) combined with antipsychotics in acute mania: a randomised controlled trial. , 2009, Bipolar disorders.
[499] J. Biederman,et al. Impact of obsessive-compulsive disorder on the antimanic response to olanzapine therapy in youth with bipolar disorder. , 2010, Bipolar disorders.
[500] Verinder Sharma,et al. Role of lamotrigine in the management of treatment-resistant bipolar II depression: a chart review. , 2008, Journal of affective disorders.
[501] T. Johnson,et al. Cognitive ^ behavioural therapy for severe and recurrent bipolar disorders Randomised controlled trial , 2006 .
[502] J. Calabrese,et al. A 6-month, double-blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid-cycling bipolar disorder and Co-occurring substance abuse or dependence. , 2009, The Journal of clinical psychiatry.
[503] J. Calabrese,et al. Predictive value of early improvement in bipolar depression trials: a post-hoc pooled analysis of two 8-week aripiprazole studies. , 2010, Psychopharmacology bulletin.
[504] M. Stoll,et al. Pediatric , 1997, Bone Marrow Transplantation.
[505] G. L’italien,et al. Influence of medication choice and comorbid diabetes: the cost of bipolar disorder in a privately insured US population , 2007, Social Psychiatry and Psychiatric Epidemiology.
[506] E. Brietzke,et al. A Randomized Controlled Trial of Cognitive Behavioral Group Therapy for Bipolar Disorder , 2011, Psychotherapy and Psychosomatics.
[507] R. Machado-Vieira,et al. Bipolar I and II disorder residual symptoms: Oxcarbazepine and carbamazepine as add-on treatment to lithium in a double-blind, randomized trial , 2009, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[508] J. Mullen,et al. Rates of remission/euthymia with quetiapine in combination with lithium/divalproex for the treatment of acute mania. , 2007, Journal of affective disorders.
[509] J. Menzin,et al. Predictors of medication nonadherence and hospitalization in Medicaid patients with bipolar I disorder given long-acting or oral antipsychotics , 2011, Journal of medical economics.
[510] T. Suppes,et al. Effectiveness of the New Extended-release Formulation of Quetiapine as Monotherapy for the Treatment of Acute Bipolar Depression (Trial D144CC00002) , 2009, European Psychiatry.
[511] S. Nasr,et al. Absence of mood switch with and tolerance to modafinil: a replication study from a large private practice. , 2006, Journal of affective disorders.
[512] A. Lane,et al. Postnatal depression and elation among mothers and their partners: Prevalence and predictors , 1997, British Journal of Psychiatry.
[513] D. David,et al. The efficacy of cognitive-behavioral therapy in bipolar disorder: a quantitative meta-analysis. , 2010, The Journal of clinical psychiatry.
[514] K. Chang,et al. Acute treatment of pediatric bipolar I disorder, manic or mixed episode, with aripiprazole: a randomized, double-blind, placebo-controlled study. , 2009, The Journal of clinical psychiatry.
[515] T. Suppes,et al. Maintenance treatment for patients with bipolar I disorder: results from a north american study of quetiapine in combination with lithium or divalproex (trial 127). , 2009, The American journal of psychiatry.
[516] M. Berk,et al. The efficacy of N-acetylcysteine as an adjunctive treatment in bipolar depression: an open label trial. , 2011, Journal of affective disorders.
[517] J. Calabrese,et al. Manic symptoms during depressive episodes in 1,380 patients with bipolar disorder: findings from the STEP-BD. , 2009, The American journal of psychiatry.
[518] J. VanMeter,et al. A prospective study of cognitive fluency and originality in children exposed in utero to carbamazepine, lamotrigine, or valproate monotherapy , 2009, Epilepsy & Behavior.
[519] J. Amsterdam,et al. Fluoxetine monotherapy of bipolar type II and bipolar NOS major depression: a double-blind, placebo-substitution, continuation study , 2005, International clinical psychopharmacology.
[520] J. Fleck,et al. Aripiprazole augmentation in treatment-resistant bipolar depression: Early response and development of akathisia , 2007, Progress in Neuro-psychopharmacology and Biological Psychiatry.
[521] L. Naldi,et al. Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study. , 2008, The Journal of investigative dermatology.
[522] N. Ryan,et al. Comorbid anxiety in children and adolescents with bipolar spectrum disorders: prevalence and clinical correlates. , 2010, The Journal of clinical psychiatry.
[523] Verinder Sharma,et al. Revisiting the association between endometriosis and bipolar disorder. , 2011, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.
[524] M. Tohen,et al. A 7-week, randomized, double-blind trial of olanzapine/fluoxetine combination versus lamotrigine in the treatment of bipolar I depression. , 2006, The Journal of clinical psychiatry.
[525] A. Tremblay,et al. Management of Antipsychotic-Induced Weight Gain: Prospective Naturalistic Study of the Effectiveness of a Supervised Exercise Programme , 2007, The Australian and New Zealand journal of psychiatry.
[526] M. Sajatovic,et al. Psychiatric comorbidity in older adults with bipolar disorder , 2006, International journal of geriatric psychiatry.
[527] D. Kupfer,et al. The longitudinal course of cognition in older adults with bipolar disorder. , 2009, Bipolar disorders.
[528] Cigarette smoking is associated with suicidality in bipolar disorder. , 2009, Bipolar disorders.
[529] L. Rohde,et al. Aripiprazole in Juvenile Bipolar Disorder Comorbid with Attention-Deficit/Hyperactivity Disorder: An Open Clinical Trial , 2007, CNS Spectrums.